ccap.ai

Public data, unclaimed profile

South African private investment vehicle founded by Nic Kohler, Willem Roos, Michael Jordaan and Roger Grobler, who have invested together since 2016. Targets businesses that gain outsized advantages from data-driven decision-making and advanced technology, notably AI. Co-acquirer of Vertice MedTech with Amethis and Proparco (2026). Detailed thesis not published: directory-only profile, outside matching.

At a glance

Based on observed investment behaviour: 1 recorded deal

Investor type: Private equity or venture capital fund (inferred, not verified)
Capital type: Private equity (inferred from profile)
Observed ticket: Data unavailable
Countries: South Africa (1)
Activities: Medical devices and equipment (1)
Instruments: Equity (1)
Stages: Growth (1)
Recent activity: 1 deal in 12 months, latest Apr 2026

Stated thesis versus observed behaviour

Fewer than three recorded deals: insufficient evidence to compare thesis and behaviour.

Does this fund fit your project?

Describe your need: the target list shows, for each source of capital, why it fits and which deals prove it.

Find my matches

Investment thesis

Criteria inferred from recorded deals: the fund has not stated its thesis yet.

Investment ticket: n/a
Instruments: Equity*
Preferred sectors: Healthcare*
Target geographies: South Africa*
Stages (stated by the fund and from its deals): Growth
Website: https://ccap.ai

Team and contacts

Willem Roos — Partner

LinkedIn profiles, emails and phone numbers are reserved for signed-in members: create an account to access them.

Reference deals

Recent public deals: they say better than a thesis what the fund actually signs.

Vertice MedTech

April 2026 · South Africa

GrowthUndisclosed amountEquityHealthcareCo-Invest

Co-investor alongside Amethis

Activity : Medical devices and equipment

Instrument : Consortium buyout with management (seller: Ethos Private Equity)

Southern Africa's leading independent distributor of specialised medical devices and a healthcare software provider: 780 staff, 3 distribution centres, 7,000+ surgical procedures a month, exclusive agreements with 100+ manufacturers (Abbott, Stryker…). Acquired from Ethos Private Equity by Amethis, Proparco, ccap.ai and management.

Why they invested

Independent leader with exclusive agreements with major manufacturers
Data- and software-driven healthcare platform
Management co-investing

Advisers

Investec — financement, buyer side
Bowmans — juridique (Amethis), buyer side
DLA Piper — juridique (Proparco), buyer side
Husemeyer Advisors — juridique (ccap.ai), buyer side
FTI — due diligence financière, buyer side
Cadena — due diligence commerciale, buyer side
SLR — ESG et impact, buyer side
Nedbank CIB — transaction, seller side
Webber Wentzel — juridique, seller side
EY — financier, seller side

Team

Hendri Pretorius — CEO
Jonathan Lowick — CFO

Co-investors Proparco (Co-Lead)

Source : amethis.comN1 · Primary source

In short

ccap.ai invests across the following sectors: Healthcare, in the following areas: South Africa. Check in 30 seconds whether your company fits these criteria.

Check my eligibility for this fund Do you represent this fund? Claim this profile